Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variations might increase the risk of a hair loss condition in Koreans.

The nude gene causes skin cell overgrowth and improper development, leading to hair and urinary issues.

SOX11 and SOX4 help skin cells act like embryonic cells to heal wounds in mice.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

The TGF-β family helps control how cells change and move, affecting skin, hair, and organ development.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

A gene deletion causes the "hairless" trait in Iffa Credo rats.

A genetic marker linked to a type of hair loss was found in most patients studied.

The PTGER2 gene is highly active in Cashmere goat skin and its activity changes with the hair growth cycle.

CT60 polymorphism might increase the risk of Alopecia Areata.

The prolactin gene polymorphism doesn't affect cashmere quality in these goats.

A new MTX2 gene mutation caused a severe genetic disorder in a young Chinese girl.

Ishige sinicola extract helps bone-building cells grow and mature, which could aid in treating osteoporosis.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Genetic variants in CYP genes may worsen PCOS symptoms.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

A gene mutation in mice causes hair loss, weak bones, and protein buildup, showing how protein processing issues can lead to diseases.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

MC4R gene variants not linked to female hair loss.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.